Oestrogen synthesis, sites of action and metabolism
Androgens are produced by the thecal cells and, in general, they are taken up by the granulosa cells and converted by P450aromatase to various oestrogens with the main one being oestradiol (Fig. 1) . In some species, such as pigs (Lautincik et al., 1994; Shores and Hunter, 1999) , chickens (Kato et al., 1995) and tree shrews (Kimura et al., 2000) , the thecal cells can also synthesize oestrogen. This steriod hormone is then released into the vasculature and circulated to the uterus, hypothalamus, mammary gland and various other reproductive and non-reproductive organs. Oestrogens may also exert local effects within the ovary. Some oestrogens appear also to be metabolized into presumed inactive as well as active products, such as the catecholoestrogens (Zhu and Conney, 1998;  Fig. 1 ).
Catecholoestrogens
The enzymes, 2-hydroxylase (cyp1a1) and 4-hydroxylase (cyp1b1) catalyse the formation of catecholoestrogens from oestradiol ( Fig. 1) . Both of these catecholoestrogens can bind to the two known oestrogen receptors, ERα and ERβ (Kuiper et al., 1997) . In addition, it has been proposed that they bind to a novel oestrogen receptor (Das et al., 1997) and possibly Oestrogen regulates several hypothalamic and pituitary hormones, which in turn control ovarian functions. Oestrogen and its metabolites, such as catecholoestrogens, also have direct effects within the ovary. This review examines the roles of oestrogen in regulating ovarian folliculogenesis, ovulation and corpus luteum formation. Oestrogen promotes follicular development, which culminates in ovulation, by potentiating follicular development, granulosa cell expression of gonadotrophin receptors, steroidogenesis, and gap junction formation by granulosa cells, and by inhibiting granulosa cell apoptosis. In addition, oestrogen may be needed for corpus luteum formation and maintenance. Studies on mutant mice that either lack one or both of the known oestrogen receptors or are unable to synthesize oestrogen support some but not all of these prior inferences of the roles of oestrogen within the ovary. Although these transgenic mice have proved useful in determining some of the intraovarian actions of oestrogen, they present confounding problems, including hormonal imbalances, that hinder interpretation. Transgenic mice with conditional or tissue-directed mutations in their oestrogen receptors are needed to dissect the ovarian actions of oestrogen further. In addition, microarray technologies, combined with specific hormone treatment regimens are likely to provide an attractive, alternative approach to using mutant mice in clarifying the direct actions of oestrogen in the ovaries of other species.
even androgen receptor (Hudson and Hillier, 1985) . Pig and human ovaries contain high concentrations of 2-hydroxylase and 4-hydroxylase (Hammond et al., 1986; Muskhelishvili et al., 2001) , and certain ovarian responses appear to be induced directly by these steroid metabolites, as discussed further below. The pattern of expression of these enzymes has not been examined throughout the oestrous cycle.
Oestrogen receptors
Oestrogen was the first steroid hormone demonstrated to activate transcription by binding to a receptor, the oestrogen receptor (for review, see Jensen and DeSombre, 1973) . The receptors with their bound hormone modulate transcription by binding to oestrogen response elements (ERE) present on oestrogen-inducible genes (Kumar et al., 1987) . The receptors can also act as co-regulators through binding to other transcription factors already attached to gene regulatory regions (Adler et al., 1988; Feng et al., 1998) , and by ligand-independent mechanisms (IgnarTrowbridge et al., 1992) . Although it was first believed that oestrogen receptors were predominantly cytoplasmic, it was later proposed that they are located exclusively within the nucleus (Welshons et al., 1984; Greene et al., 1986) . It is now clear that these receptors can be found in both the cytoplasm and nucleus, with the ratio dependent upon the cell type and physiological conditions (Yamashita, 1998; Zieba et al., 2000) . Some studies also indicate that oestrogen receptors reside on the plasma membrane and modulate cellular activity without directly associating with DNA (Morley et al., 1992; Levin, 1999; Pietras and Szego, 1999; Nadal et al., 2000) .
The oestrogen receptors are members of the superfamily of steroid nuclear receptors (Parker, 1995; Baker, 1997; White and Parker, 1998) . All steroid receptors have a DNAbinding domain that is composed of two zinc fingers followed by a C-terminal ligand-binding domain (Parker, 1995; White and Parker, 1998) . Currently, two oestrogen receptors, ERα (Green et al., 1986; Greene et al., 1986) and ERβ (Kuiper et al., 1996; Mosselman et al., 1996) have been cloned. These two receptors have considerable sequence identity in the DNA-binding domains, which permit both receptor types to interact with EREs of various genes. Sequence differences between the two receptors occur primarily in the N-and C-terminal regions (Kuiper et al., 1996; Mosselman et al., 1996) .
There are many alternatively spliced forms of both ERα and ERβ (Chu and Fuller, 1997; Petersen et al., 1997; Kos et al., 2000; Poola et al., 2000) . The alternatively spliced forms of ERα have been identified predominantly in human breast cancer and other tumour cell lines (Kos et al., 2000; Poola et al., 2000) but not in normal ovarian cells. One alternative form of ERβ identified in rats lacks exon 4, which forms the second zinc finger of the DNA-binding domain, whereas another form has 18 additional codons in the ligandbinding domain, which results in a protein with only 10% of the oestradiol-binding affinity and 100-to 1000-fold lower transcriptional activation potential compared with the full length receptor (Petersen et al., 1997) . This form with 18 additional amino acids appears to be the predominant ERβ in various mouse organs, including the ovary (Lu et al., 2000) . A third form of ERβ described in rats carries a deletion of the second zinc finger, as well as the 18 additional codons in the ligand-binding domain (Petersen et al., 1997) (Fig. 2) . All three of these aforementioned forms have been identified in C. S. Rosenfeld et al. the rat ovary (Petersen et al., 1997) , and thus, each may regulate oestrogenic activity in the rodent ovary. In addition, other novel human ERβ forms, which differ in their Cterminal sequences, have been identified, and some of these are expressed in the human ovary (Moore et al., 1998) .
2-Hydroxyoestradiol
The discovery of ERβ raises the question as to whether mammals possess additional oestrogen receptors that have yet to be identified. No such genes have been identified to date in the human genome, although there is some evidence for at least one additional oestrogen receptor in the mouse ovary and uterus (Kudolo et al., 1984a,b; Hillier et al., 1989; Das et al., 1997; Ghosh et al., 1999; for review, see Rosenfeld et al., 2001 ). Moreover, a third oestrogen receptor, ERγ, has been identified in fish (Hawkins et al., 2000) . ERγ is distinct from other fish ERαs and ERβs, but is quite closely related to ERβ. In mammals, alternatively spliced forms of ERα and ERβ that differ in their ligandbinding domains may represent novel oestrogen receptors because these mutations might alter their ability to interact with various endogenous oestrogens, their metabolites and antagonists.
For oestrogens to act on specific cell types in the ovary, ovarian oestrogen receptors must be present, and oestrogeninduced gene activation generally occurs. The ovarian cell types in which ERα and ERβ have been identified are listed (Table 1) . In all species studied to date, ERβ is the most abundant ovarian oestrogen receptor. This receptor is especially prominent in granulosa cells, but it is also expressed in luteal cells and, to a lesser extent, in thecal cells (see references in Table 1 ).
Regulation of ovarian oestrogen receptor expression
As in other oestrogen-responsive organs, such as the uterus, oestrogen downregulates granulosa cell expression of ERβ protein (Sharma et al., 1999) . In rodents, treatment with gonadotrophins, in particular LH, results in a marked decrease of ERβ in the ovary (Byers et al., 1997; Fitzpatrick et al., 1999) . This effect is mediated through a cAMPdependent pathway. Not surprisingly, addition of cAMP to cultured rat granulosa cells also decreases ERβ expression (O'Brien et al., 1999) . In contrast, when cattle are infused with ovulatory dosages of LH, ovarian ERβ concentrations are not altered (Manikkam et al., 1999) . Why this species difference occurs is not clear, but it may relate to the manner in which follicular maturation and selection occurs in the two species, that is, polyovulatory rodents versus generally monovulatory cattle. ERβ may regulate early follicular growth in rodents, whereas it may exert control over both early and late follicular development in cattle.
Mice that lack LH-hCG receptors have a marked decrease in ovarian ERα mRNA, but an increase in ovarian ERβ mRNA expression, as determined by northern blot analysis (Lei et al., 2001) . Oestrogen and progesterone treatment of these mice restores ERα mRNA to the amounts found in wild-type mice, but ERβ mRNA remains increased. These findings support the contention that LH signalling is needed in mice to maintain proper ovarian ERβ mRNA concentrations. Concomitantly, the absence of ERα results in increased serum concentrations of LH (Rissman et al., 1997; Couse and Korach, 1999) , and thus, ERα is needed to maintain normal LH concentrations.
Intraovarian effects of oestrogen

Folliculogenesis
As the ovarian follicles grow and differentiate, increasing amounts of oestrogen are produced (Fortune, 1994) , which, in turn, upregulate the synthesis and release of the pituitary gonadotrophins, FSH and LH, thereby promoting ovarian follicular growth. On the basis of some reports, oestrogen directly increases the number and size of ovarian follicles in vivo and the size of rat, mouse and bovine follicles in culture (Goldenberg et al., 1972; Nakayama et al., 1981; Nakano et al., 1982; Gore-Langton and Daniel, 1990; Nayudu and Osborn, 1992; Hulshof et al., 1995) . However, other studies on rat and ovarian follicles have not supported this finding (Coney et al., 1987; Spears et al., 1998) .
If oestrogen is indeed directly promoting ovarian follicular growth, it is uncertain which oestrogen receptors are involved. Both the ERα knockout (ERαKO) (Rosenfeld et al., 2000) and ERβKO (Krege et al., 1998) mice exhibit follicular development to the Graafian stage, albeit to a lesser extent than in wild-type sibling mice. However, ERαβ double KO mice are infertile because of follicular arrest (Couse et al., 1999; Dupont et al., 2000) . Nevertheless, early follicular growth and development occurs in these mice, even though mature Graafian follicles do not form. Collectively, these results indicate that, in mice, ERα or ERβ can compensate, at least partially, for the absence of the other to provide mature ovulatory follicles, but may not be necessary for the earlier stages of follicular growth.
Aromatase knockout (ArKO) mice can complete folliculogenesis without exogenous oestrogens, but the process is impaired, with fewer follicles reaching maturity than in wild-type controls (Fisher et al., 1998; Britt et al., 2000) . ArKO mice that are treated with oestradiol every 4 days from 4 weeks of age for 1 month have increased numbers of follicles compared with untreated ArKO mice. However, these treated mice still do not develop corpora lutea (Toda et al., in press ). On the basis of these data, folliculogenesis can occur, albeit sub-normally, in the absence of either oestrogen or one of its two known receptors.
Gonadotrophin receptor expression
Growing follicles express gonadotrophin receptors. Before selection, follicles express FSH receptors, but LH receptors emerge later in the dominant follicles. In cattle, when the dominant follicles are first selected, FSH reaches its nadir (Fortune, 1994) while serum concentrations of LH begin to increase. It is presumed that only those follicles that express LH receptors in granulosa cells can be rescued and, in time, ovulated.
Oestrogen increases follicular expression of both FSH and LH receptors in rat granulosa cells (Richards et al., 1976 (Richards et al., , 1979 . Those follicles that first begin to produce significant amounts of oestrogen are more likely to possess more gonadotrophin receptors. Therefore, whether or not a particular follicle expresses oestrogen receptors may control its fate. However, ERαKO mice have increased expression of granulosa and thecal LH receptor (Schomberg et al., 1999) , again indicating a lack of ERα involvement in control of follicular growth. These mice also have increased serum oestrogen concentrations, which may increase granulosa cell expression of LH receptor by acting through ERβ or one of the putative additional receptor types. There is currently no information on the ovarian expression of FSH and LH receptors in ERβKO and ERαβ double KO mice. If oestrogen acts through ERβ to upregulate gonadotrophin receptor expression, ERβ mutant mice presumably would have decreased expression of FSH and LH receptors.
Steroid production
Ovarian steroid hormones are produced throughout the oestrous cycle. During folliculogenesis, the thecal cells produce androgens, which are converted into oestrogens by P450aromatase in the granulosa cells. Both oestradiol (Fortune and Hansel, 1979; Leung and Armstrong, 1980; Welsh et al., 1983; Roberts and Skinner, 1990 ) and catecholoestrogens (Spicer and Hammond, 1987; Tekpetey and Armstrong, 1994) can regulate the production of androgen and progesterone within bovine, rat and pig ovaries. Oestrogen is known to increase CYP17 expression by rat theca cells (Johnson and Crane, 1995) . The oestrogen-driven increase in progesterone presumably promotes corpus luteum formation and maintenance through luteal progesterone receptors (Duffy and Stouffer, 1995; Smith et al., 1995) . 
Promotes folliculogenesis
Gap junctions
As the follicles continue to grow and proliferate, the avascular granulosa cell lining becomes removed from the nutrient-providing interstitial blood vessels. Gap junctions permit transfer of nutrients and cytokines to and from the granulosa cells and developing oocytes (Albertini and Anderson, 1974; Anderson and Albertini, 1976) . Oestrogen controls granulosa cell gap junction formation (Merk et al., 1972; Burghardt and Anderson, 1981) . Gap junctions are composed of various connexin proteins: connexin 43 is a major granulosa and luteal gap junction protein in bovine (Nuttinck et al., 2000) , ovine (Grazul-Bilska et al., 1998), pig (Lenhart et al., 1998) and rat (Mayerhofer and Garfield, 1995) ovaries, and is oestrogen-regulated (Yu et al., 1994) . One method whereby oestrogen might potentiate gap junction formation between granulosa cells is through induction of this protein. However, connexin 43 protein expression has not been reported in any of the oestrogen receptor or P450arom mutant female mice.
Apoptosis
Most follicles do not reach the ovulatory stage but instead become atretic owing to apoptosis of the granulosa cell lining (Kaipia and Hsueh, 1997; Amsterdam et al., 1999) . This process is normally tightly regulated with anti-and proapoptotic factors balancing each other, and with crosstalk among multiple intracellular pathways determining the final outcome of the cell (Kaipia and Hsueh, 1997; Amsterdam et al., 1999) . Oestrogen inhibits granulosa cell apoptosis (Billig et al., 1993) . In contrast, androgens promote apoptosis (Billig et al., 1993) .
As with other ovarian processes, it is uncertain which oestrogen receptors are mediating this oestrogenic antiapoptotic effect. In addition, it is not clear whether there are physiological repercussions if the anti-apoptotic mechanism is perturbed. In 10-12-week-old ArKO mice, many apoptotic granulosa cells are present in large antral follicles (Britt et al., 2000) , and by 21-23 weeks of age, these mice have fewer antral follicles than do wild-type controls. Predictably, ArKO mice have increased ovarian expression of pro-apoptotic genes, such as p53 and Bax, compared with wild-type mice (Toda et al., in press). At 1 year of age, the ArKO mice have a reduced number of primary follicles, all of which contain numerous apoptotic cells (Britt et al., 2000) . By contrast, ERαKO mice have similar numbers of apoptotic granulosa cells when compared with wild-type control mice (Schomberg et al., 1999) . Although oestrogen may be essential for preventing the demise of ovarian follicles, this protection is clearly not conferred through ERα.
Corpus luteum formation and maintenance
Early studies with hypophysectomized or X-irradiated rabbits and rats with hypothalamic lesions indicated that oestrogen directly regulates corpus luteum formation and controls luteal maintenance (Robson, 1937; Bogdanove, 1966; Keyes and Nalbandov, 1967) . Unexpectedly, ERβKO mice demonstrate normal corpus luteum development, but have an overall reduced fertility (Krege et al., 1998) . Prepubertal ERαKO mice treated with superovulatory dosages of gonadotrophins also develop steroidogenically functional corpora lutea, but they remain infertile (Rosenfeld et al., 2000) . Thus, the phenotypes of these mutant mice do not corroborate earlier studies. In contrast, ArKO and ERαβ double KO mice do not undergo luteinization and corpus luteum formation (Fisher et al., 1998; Couse et al., 1999; Britt et al., 2000; Dupont et al., 2000) . Taken together, these findings indicate that oestrogen is indeed needed for corpus luteum formation and maintenance, and that it likely acts non-selectively through ERα or ERβ with one oestrogen receptor compensating for the absence of the other. If both receptors are lacking, oestrogen cannot stimulate luteinization.
Non-genomic actions of oestrogen within the ovary
The complex physiological responses to oestrogen are generally presumed to involve transcriptional regulation of many genes. However, oestrogen-binding to putative membrane oestrogen receptors (Levin, 1999) may also induce non-genomic-non-transcriptionally mediated responses. In cultured granulosa cells, oestrogen has been implicated in causing a rapid increase in intracellular Ca 2+ concentrations (Morley et al., 1992) . As this response occurs within seconds of treating the cells with oestrogen, a reasonable conclusion is that it is occurring without transcriptional activation, that is, it is elicited through some existing membrane-associated response. The demonstration that ERα associates with the regulatory subunit of phosphatidylinositol-3-OH kinase (PI(3)K) in the presence of ligand may provide at least a partial explanation for the non-genomic effects of oestrogen (Simoncini et al., 2000) , and thus provide another dimension to oestrogenic action within the ovary. Non-genomic responses have not yet been studied in transgenic mice.
Confounding problems in interpreting ovarian phenotypes in oestrogen-and oestrogen receptordeficient mice
Although these knockout mice have proved invaluable in elucidating some of the roles of oestrogen within the ovary, Intraovarian actions of oestrogen 221 Fig. 3 . Illustration of the proposed intraovarian actions of oestrogen. On the basis of past pharmacological, surgical, and culture approaches, oestrogen modulates many ovarian responses, including promoting folliculogenesis, increasing granulosa cell gonadotrophin receptor expression, increasing gap junction formation between granulosa cells, increasing steroid production by both thecal and luteal cells, and inhibiting granulosa cell apoptosis. E 2 : oestrogen; LH-R: LH receptor, FSH-R: FSH receptor.
confounding factors hinder interpretation of the resulting ovarian phenotypes. In rodents, only one P450aromatase gene has been identified and knocked out (Youngblood et al., 1989; Fisher et al., 1998; Honda et al., 1998) . However, such mice are likely to have been exposed in utero to maternal oestrogen and postnatally to other sources of oestrogen, including compounds in the environment and diet, which would hinder interpreting the reproductive phenotypes of the adult animals. Furthermore, it is now apparent that there are non-aromatized steroid molecules, such as hermaphrodiol, that have both androgenic and oestrogenic activity (Lima et al., 2000; Rosenberg-Zand et al., 2000) . Therefore, proper interpretation of ovarian phenotypes in ArKO mice requires exclusion of all sources of both aromatic and non-aromatic oestrogenic molecules. In addition, ArKO mice have secondary hormonal imbalances, such as increased serum concentrations of LH, FSH and androgen, which may account for some of the ovarian pathology (Fisher et al., 1998) . The ERKO mice also have secondary hormonal imbalances, including an increase in serum LH, which is present in both ERαKO (Rissman et al., 1997; Couse and Korach, 1999) and ERαβ double KO (Couse et al., 1999a) mice. In ERKO mice, all receptors that bind oestrogen have to be considered and deleted before it is possible to make accurate inferences about which oestrogen receptors mediate the intraovarian effects of oestrogen. Novel oestrogen receptors may be discovered once the mouse and human genomic sequences are fully annotated and the properties of forms arising by alternative splicing elucidated. It is interesting to note that the orphan oestrogen-related receptors (ERRα, β, and γ), the endogenous ligands of which are unknown, have been demonstrated, albeit with low affinity, to bind diethylstilboestrol (DES) but not oestradiol (Tremblay et al., 2001) . Thus, the ERRs may play a role in oestrogenic actions within the ovary, although as yet these receptors have not been examined fully in the ovary.
Ultimate resolution of these difficulties may depend on the creation of more sophisticated approaches to producing mutant mice that have ovarian cell-specific and conditional ablation of oestrogen receptors. Production of such mice would permit a thorough analysis of the effects of oestrogen-binding to oestrogen receptors throughout the oestrous cycle and pregnancy and would have minimal confounding hormonal imbalances. Transgenic mice with tamoxifen-dependent Cre recombinase fused to a mutated ligand-binding domain of human oestrogen receptor have been produced (Metzger and Chambon, 2001 ) and, when these mice are treated with tamoxifen, the chromosomally integrated gene, which is flanked by loxP sites, is excised.
Studying the intraovarian actions of oestrogen in other species
It is worth considering whether the mouse is the best model with which to study the intraovarian effects of oestrogen. Is it possible, for example, to extrapolate from responses seen in rodents to other species? Although women, cows and mares are generally monovulatory, rodents are polyovulatory, and thus, the regulation of folliculogenesis may be different. How then can the in vivo effects of oestrogen in the ovaries of other species be studied, where the targeted deletion of genes is not currently possible? Microarray technology could be invaluable in this respect and provide comparison of oestrogen-regulated genes in various ovarian cells during puberty, the oestrous cycle, pregnancy and in response to oestrogenic treatment. This technique could be used in combination with pharmacological blockage of one or more oestrogen receptors to provide multiple snapshots of the intraovarian effects of oestrogen. An ovarian gene database (http://ovary.stanford.edu; Melner and Korach, 2000) has been established that may assist in the identification of all the oestrogen-regulated ovarian genes.
Regulation of oestrogen action within the ovary
Although there is ample evidence that oestrogen acts within the ovary, it also originates there, and is present in highest concentrations in this organ. Such quantities would in theory continually saturate and activate any cognate receptors, and potentially result in either continual transcriptional activation or other consequences such as desensitization. Some regulation of this system must occur to prevent such scenarios. One regulatory step could be at the receptor level. Oestrogen receptors may be required for only a limited period of follicular development but persist thereafter in a subfunctional state. Co-activators may provide another level of regulation. These factors act in concert with oestrogen receptors to induce transcription of oestrogen-responsive genes. Various transcription factors, such as SRC-1, GRIP1, RAC3, p300, SPA AIB1, RIP140, SMRT, Fas-associated protein-tyrosine phophatase-1 (FAP-1), and co-activator independent of AF-2 function (CIA) that regulate oestrogen-responsive genes have been identified (Rey et al., 2000; Hlaing et al., 2001; Sauve et al., 2001) . Possibly, it is their specific expression pattern and not that of the cognate receptors that governs the oestrogen responsiveness of granulosa and other ovarian cells. Differential expression of some of the oestrogen receptor co-activators supports this hypothesis (Hlaing et al., 2001) . Although granulosa, thecal and stromal cells in ovine ovaries express SRC-1, RIP140 and SPA mRNA, granulosa cells have the highest mRNA expression for these coactivators (Hlaing et al., 2001) . Similarly, the ovine corpus luteum expresses smaller amounts of SRC-1 and RIP1240 mRNA than do follicular cells (Hlaing et al., 2001) .
A third form of regulation may be through metabolism of oestrogen by the cyp enzymes into various active and inactive metabolites. Compounds, such as the catecholoestrogens, may bind oestrogen receptors (Kuiper et al., 1997), androgen receptor (Hudson and Hillier, 1985) and other novel steroid receptors (Das et al., 1997 (Das et al., , 2000 , resulting in responses both quantitatively and qualitatively distinct from the parental steroid. How efficiently the various ovarian cells convert oestradiol into these metabolites might provide another level of control.
In summary, selective expression of oestrogen receptors, co-activational factors, and metabolic conversion of oestradiol may regulate the intraovarian effects of oestrogen. Similar processes could be invoked in other tissues in which a hormone acts within its originating tissue. For example, progesterone receptors are found in the bovine and primate corpus luteum (Smith et al., 1995; Duffy and Stouffer, 1995) .
Conclusions
The intraovarian effects of oestrogen have been examined. Early work indicated that oestrogen directly regulates ovarian folliculogenesis, corpus luteum formation, granulosa cell expression of the gonadotrophin receptors, gap junction formation between granulosa cells, granulosa cell apoptosis and steroid production by granulosa, thecal and luteal cells (Fig. 3) . These actions are presumably regulated by specific oestrogen receptors. ERβ is the predominant form of oestrogen receptor found in the ovary (Byers et al., 1997; Couse et al., 1997) .
Aromatase-deficient and oestrogen receptor-deficient mice have been created to study the effects of oestrogen. Although results from these mice support a role for oestrogen in the ovary, some of the data are equivocal, such that the phenotypes cannot always be directly attributed to the absence of the gene, since secondary hormonal imbalances and other confounding factors invariably occur in these mice. More sophisticated, tissue-targeted knockout mice are needed to elucidate the roles of oestrogen within the ovary. The involvement of oestrogen in ovarian physiology needs to be examined in several species before any firm and general conclusions can be drawn about its intraovarian effects. 
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